↓ Skip to main content

Stem Cell Therapy for Autism

Overview of attention for article published in Journal of Translational Medicine, June 2007
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news
1 news outlet
twitter
35 X users
patent
1 patent
facebook
3 Facebook pages

Citations

dimensions_citation
56 Dimensions

Readers on

mendeley
188 Mendeley
citeulike
1 CiteULike
connotea
1 Connotea
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Stem Cell Therapy for Autism
Published in
Journal of Translational Medicine, June 2007
DOI 10.1186/1479-5876-5-30
Pubmed ID
Authors

Thomas E Ichim, Fabio Solano, Eduardo Glenn, Frank Morales, Leonard Smith, George Zabrecky, Neil H Riordan

Abstract

Autism spectrum disorders (ASD) are a group of neurodevelopmental conditions whose incidence is reaching epidemic proportions, afflicting approximately 1 in 166 children. Autistic disorder, or autism is the most common form of ASD. Although several neurophysiological alterations have been associated with autism, immune abnormalities and neural hypoperfusion appear to be broadly consistent. These appear to be causative since correlation of altered inflammatory responses, and hypoperfusion with symptology is reported. Mesenchymal stem cells (MSC) are in late phases of clinical development for treatment of graft versus host disease and Crohn's Disease, two conditions of immune dysregulation. Cord blood CD34+ cells are known to be potent angiogenic stimulators, having demonstrated positive effects in not only peripheral ischemia, but also in models of cerebral ischemia. Additionally, anecdotal clinical cases have reported responses in autistic children receiving cord blood CD34+ cells. We propose the combined use of MSC and cord blood CD34+cells may be useful in the treatment of autism.

X Demographics

X Demographics

The data shown below were collected from the profiles of 35 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 188 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 1%
Netherlands 1 <1%
Germany 1 <1%
India 1 <1%
China 1 <1%
Unknown 182 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 35 19%
Researcher 24 13%
Student > Master 23 12%
Student > Ph. D. Student 20 11%
Other 14 7%
Other 44 23%
Unknown 28 15%
Readers by discipline Count As %
Medicine and Dentistry 57 30%
Agricultural and Biological Sciences 35 19%
Biochemistry, Genetics and Molecular Biology 19 10%
Psychology 8 4%
Social Sciences 7 4%
Other 31 16%
Unknown 31 16%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 36. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 April 2024.
All research outputs
#1,147,967
of 25,658,139 outputs
Outputs from Journal of Translational Medicine
#232
of 4,692 outputs
Outputs of similar age
#1,907
of 78,986 outputs
Outputs of similar age from Journal of Translational Medicine
#1
of 5 outputs
Altmetric has tracked 25,658,139 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,692 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.0. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 78,986 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 5 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them